Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)Product type:AdviceProgramme:Evidence summaryPublished: 5 January 2021
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)Product type:AdviceProgramme:Evidence summaryPublished: 11 May 2022
Cellulitis and erysipelas: antimicrobial prescribing (NG141)Product type:GuidanceProgramme:NICE guidelinePublished: 27 September 2019
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma (TA720)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 August 2021
Difficult-to-treat scabies: oral ivermectin (ESUOM29)Product type:AdviceProgramme:Evidence summaryPublished: 18 March 2014
Dupilumab for treating moderate to severe prurigo nodularis (TA955)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 March 2024
Endoscopic ablation for a pilonidal sinus (IPG646)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 17 April 2019
Impetigo: antimicrobial prescribing (NG153)Product type:GuidanceProgramme:NICE guidelinePublished: 26 February 2020
InterDry for intertrigo (MIB192)Product type:AdviceProgramme:Medtech innovation briefingPublished: 10 September 2019
Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing (NG190)Product type:GuidanceProgramme:NICE guidelinePublished: 2 March 2021
Secukinumab for treating moderate to severe hidradenitis suppurativa (TA935)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 December 2023